Media

Media

Emcure Pharmaceuticals Signs Agreement with Gilead for the Manufacture and Global Supply of Lenacapavir
03.10.2024
Download

Emcure Pharmaceuticals Announces Strong Q1FY25 Results with 17% Revenue Growth and 16% EBITDA Growth
13.08.2024
Download

Emcure Pharmaceuticals strengthens its commitment to energy conservation, signs PPA with Sunsure Energy for solar power.
25.07.2024
Download

Quick Explore

Left Nav
Right Nav